» Articles » PMID: 34594708

Acute Hepatitis B - China, 2005-2019

Overview
Journal China CDC Wkly
Date 2021 Oct 1
PMID 34594708
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Trends and Age-Period-Cohort Effect on Acute Hepatitis B Incidence - China, 2005-2021.

Wang L, Liu N, Miao N, Zhang G, Wang F, Wang H China CDC Wkly. 2024; 6(30):727-733.

PMID: 39114316 PMC: 11301606. DOI: 10.46234/ccdcw2024.164.


Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review.

Bai X, Chen L, Liu X, Tong Y, Wang L, Zhou M Vaccines (Basel). 2022; 10(6).

PMID: 35746510 PMC: 9227759. DOI: 10.3390/vaccines10060900.

References
1.
Cui F, Shen L, Li L, Wang H, Wang F, Bi S . Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerg Infect Dis. 2017; 23(5):765-772. PMC: 5403029. DOI: 10.3201/eid2305.161477. View

2.
Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N . Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol. 2006; 37(3):206-12. DOI: 10.1016/j.jcv.2006.06.011. View

3.
Dao D, Hynan L, Yuan H, Sanders C, Balko J, Attar N . Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels. Hepatology. 2011; 55(3):676-84. PMC: 3272543. DOI: 10.1002/hep.24732. View

4.
. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018; 3(6):383-403. DOI: 10.1016/S2468-1253(18)30056-6. View

5.
Han Y, Tang Q, Zhu W, Zhang X, You L . Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. J Gastroenterol Hepatol. 2008; 23(11):1728-33. DOI: 10.1111/j.1440-1746.2008.05600.x. View